HomeBody MapPeptidesCalculator
Catalog5 refs

Linaclotide

OtherResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Half-life
5
Uses
290 mcg
Typical
Body Map
Loading 3D model…
gut-lining cells
Overview

A 14-amino-acid synthetic peptide and guanylate cyclase-C agonist, FDA-approved for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. It binds to guanylate cyclase-C receptors in the intestine, raising cyclic GMP levels, which increases chloride and bicarbonate secretion, slows sodium reabsorption, and draws water into the gut to soften stool and speed transit. Cyclic GMP also quiets pain-sensing nerve endings in the gut wall. The peptide is minimally absorbed into the bloodstream, acting locally in the gut.

Primary Uses
IBS-C (irritable bowel syndrome with constipation)
Chronic idiopathic constipation (CIC)
Pediatric IBS-C (ages 7+)
Pediatric functional constipation (ages 2+)
Abdominal pain reduction in IBS-C
Protocol Reference
Dose
290 mcg daily (IBS-C); 145 mcg daily (CIC); 72 mcg available
Frequency
Once daily
Route
Oral capsule on empty stomach
Evidence
FDA Approved
Research References· 3
FDA Approved Labeling \- Prescribed dose ↗
PubMedPMID 22762246145 mcg daily (CIC)
https://pubmed.ncbi.nlm.nih.gov/23116208/
PubMedPMID 23116208- [https://pmc.ncbi.nlm.nih.gov/articles/PMC5770595/](https://pmc.ncbi.nlm.nih.gov/articles/PMC5770595/)
https://pubmed.ncbi.nlm.nih.gov/21651347/
PubMedPMID 21651347- [https://pmc.ncbi.nlm.nih.gov/articles/PMC3957218/](https://pmc.ncbi.nlm.nih.gov/articles/PMC3957218/)
Research Models
Human
Also in Other
Other
Abaloparatide
Osteoporosis treatment · Postmenopausal Osteoporosis
Other
ACE-031
Muscle Hypertrophy · Muscular Dystrophy
Other
ACTH (Cosyntropin)
Diagnostic tool to test adrenal gland function · Assess adrenal reserve
Other
Adrenocorticotropic hormone (ACTH)
adrenal insufficiency diagnosis · adrenal insufficiency treatment
Compare